Pharmaceutical Product Supply – Bupivacaine Hydrochloride Injection
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract involves the manufacture and supply of Bupivacaine Hydrochloride Injection USP, 0.5%, in 50 mL quantities for the Department of Defense via the Medical Supply Chain Pharm FSA. The products must strictly adhere to FDA cGMP standards and meet specific packaging and labeling requirements, including MIL-STD-129, RP001, and DLA guidelines. The opportunity is categorized under NAICS code 325412. Interested parties must submit their responses by the deadline of August 24, 2026, following the posting date of August 17, 2026.
General Info
Agency
NAICS
Place of Performance
USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-4664.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
BUPIVACAINE HYDROCH
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
